ASBP
Aspire Biopharma·NASDAQ
--
--(--)
--
--(--)
3.33 / 10
Netural
Fundamental evaluation is mixed, scoring 3.3/10. Key strengths include a healthy interest coverage ratio (15.48) and positive revenue growth (92.66% YoY in operating revenue). However, significant weaknesses such as high days sales outstanding (72.55) and an elevated PB-ROE (2.91) point to collection inefficiencies and potential overvaluation, warranting caution.
Analysis Checks(7/10)
Revenue-MV
Value-7.21
Score3/3
Weight24.22%
1M Return10.54%
Value-7.21
Score3/3
Weight24.22%
1M Return10.54%
Days sales outstanding
Value72.55
Score1/3
Weight-2.66%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.66%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight19.33%
1M Return8.45%
Value-0.17
Score2/3
Weight19.33%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.93%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.93%
1M Return-1.11%
Asset-MV
Value-0.50
Score1/3
Weight14.13%
1M Return6.68%
Value-0.50
Score1/3
Weight14.13%
1M Return6.68%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight2.07%
1M Return1.11%
Value78.47
Score2/3
Weight2.07%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight19.31%
1M Return8.45%
Value0.46
Score2/3
Weight19.31%
1M Return8.45%
PB-ROE
Value2.91
Score0/3
Weight5.76%
1M Return2.72%
Value2.91
Score0/3
Weight5.76%
1M Return2.72%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.80%
1M Return0.43%
Value92.66
Score2/3
Weight0.80%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight18.98%
1M Return8.41%
Value-0.07
Score2/3
Weight18.98%
1M Return8.41%
Revenue-MV
Value-7.21
Score3/3
Weight24.22%
1M Return10.54%
Value-7.21
Score3/3
Weight24.22%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight2.07%
1M Return1.11%
Value78.47
Score2/3
Weight2.07%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-2.66%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.66%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight19.31%
1M Return8.45%
Value0.46
Score2/3
Weight19.31%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight19.33%
1M Return8.45%
Value-0.17
Score2/3
Weight19.33%
1M Return8.45%
PB-ROE
Value2.91
Score0/3
Weight5.76%
1M Return2.72%
Value2.91
Score0/3
Weight5.76%
1M Return2.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.93%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.93%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.80%
1M Return0.43%
Value92.66
Score2/3
Weight0.80%
1M Return0.43%
Asset-MV
Value-0.50
Score1/3
Weight14.13%
1M Return6.68%
Value-0.50
Score1/3
Weight14.13%
1M Return6.68%
Cash-MV
Value-0.07
Score2/3
Weight18.98%
1M Return8.41%
Value-0.07
Score2/3
Weight18.98%
1M Return8.41%
Is ASBP undervalued or overvalued?
- ASBP scores 3.33/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, 0.00% net margin, -0.19 P/E ratio, -0.51 P/B ratio, and -19400.00% earnings growth, these metrics solidify its Netural investment rating.
